Navigation Links
FDA Approves Picato® (ingenol mebutate) Gel, the First and Only Topical Actinic Keratosis (AK) Therapy With 2 or 3 Consecutive Days of Once-Daily Dosing
Date:1/25/2012

PARSIPPANY, N.J., Jan. 25, 2012 /PRNewswire/ -- LEO Pharma announced today that the U.S. Food and Drug Administration (FDA) approved Picato® (ingenol mebutate) gel (0.015%, 0.05%) for the topical treatment of actinic keratosis (AK). AK is a precancerous condition caused by cumulative sun exposure that has the potential to progress to squamous cell carcinoma (SCC), the second most common type of skin cancer.[1],[2] Picato® 0.015% gel is used once daily on the face and scalp for three consecutive days, and Picato® 0.05% gel is used once daily on the trunk and extremities for two consecutive days.[3] Picato® gel is the first and only topical AK therapy that can be used for as little as two or three days.

(Logo:  http://photos.prnewswire.com/prnh/20120125/NY41238LOGO )

According to the American Academy of Dermatology (AAD), 1 in 5 Americans will develop skin cancer in the course of their lifetime.[4] Studies show that about 65 percent of squamous cell carcinomas begin as untreated actinic keratosis,[5] and guidelines from the AAD estimate that 60 percent of predisposed persons older than 40 have at least one actinic keratosis.[6]  

"Since there is no way to predict which actinic keratosis will advance to skin cancer, early detection and treatment of lesions are critical," said ingenol mebutate study investigator Dr. Mark Lebwohl, Department of Dermatology, Mount Sinai Medical Center, New York, New York.  "What makes this new solution particularly exciting is the two or three day course of treatment." 

In four phase III clinical studies of more than 1,000 patients with actinic keratosis, a significantly higher proportion of those treated with Picato® gel (n=503) saw complete clearance of AKs in the field of treatment as compared to placebo (n=502). The most common adverse events (AEs) were local skin reactions (LSRs), including
'/>"/>

SOURCE LEO Pharma Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... August 22, 2014 ... ) has announced the addition of the  ... to their offering.       (Logo: ... essential instrument for any modern science laboratory ... of materials. It can be broadly classified ...
(Date:8/22/2014)... , Aug. 22, 2014  As the Medical Affairs, ... many leaders in this area are exploring methods to ... The Medical Affairs Consortium at Best Practices, LLC is ... sharing insights about the key challenges they face. The ... solutions through three virtual roundtable discussions where leaders discuss ...
(Date:8/22/2014)... MC Medical, a subsidiary of Mitsubishi Corporation (MCM), and Minimally ... medical device company, have formally agreed to an exclusive ... in Japan . It is anticipated that ... in the latter half of 2015. ... in endoscopic surgery market in Japan . ...
Breaking Medicine Technology:Global Laboratory Electronic Balance Market 2014-2018: Key Vendors are A&D Company, Mettler-Toledo, Sartorius and Thermo Fisher 2Best Practices' Medical Affairs Consortium Survey Has Achieved Strong Participation 2MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2
... China, May 26, 2011 /PRNewswire-Asia/ -- Winner Medical Group ... "the Company"), a leading manufacturer of medical dressings, medical ... products in China, today announced the resignation of one ... personal reasons. Winner Medical,s Board of Directors voted to ...
... 26, 2011 Reportlinker.com announces that a ... its catalogue: Specialty Pharmaceutical ... http://www.reportlinker.com/p0512130/Specialty-Pharmaceutical-Industry---2011-Yearbook.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology Specialty Pharmaceutical ... Summary GBI Research,s "Specialty ...
Cached Medicine Technology:Winner Medical Appoints New Independent Director 2Winner Medical Appoints New Independent Director 3Winner Medical Appoints New Independent Director 4Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 2Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 3Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 4Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 5Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 6Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 7Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 8Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 9Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 10Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 11Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 12Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 13Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 14Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 15Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 16
(Date:8/23/2014)... 2014 GBI Research, the leading business ... Therapeutics in Major Developed Markets to 2020 - New ... Market”, which provides in-depth analysis of the critical care ... Japan and Canada. The report provides an estimation of ... 2020. It covers critical care indications that are being ...
(Date:8/23/2014)... Young adults in Athens, GA who find that they have ... phone and call the new helpline which can offer support and ... Troubled Teen Athens is a wonderful resource for an adolescent drug ... steps to end substance abuse once and for all. When a ... or peers when really they should put their faith in a ...
(Date:8/23/2014)... Springs, NC (PRWEB) August 23, 2014 Teen ... facing young people in Holly Springs, NC. Countless adolescents throughout ... a regular basis. Unfortunately, many never receive professional rehab ... young adults on where to get help. Troubled Teens Holly ... in the lives of local teenage alcohol abusers ...
(Date:8/22/2014)... 2014 2014 Deep Research Report ... and in-depth research report on the Glucose Meter ... including Glucose Meter definition, classification, application, and industry ... research covers the international market analysis, including domestic ... macroeconomic environment & economic situation analysis. The report ...
(Date:8/22/2014)... August 22, 2014 AWeber, one ... that currently helps more than 120,000 small businesses ... the attention of Shane Michaels, prompting an investigative review. ... element for any online marketing campaign, despite what some ... the marketing world,” reports Michaels. “AWeber is a great ...
Breaking Medicine News(10 mins):Health News:Critical Care Therapeutics in Major Developed Markets to 2020 | Researchmoz 2Health News:Critical Care Therapeutics in Major Developed Markets to 2020 | Researchmoz 3Health News:Teenagers in Athens, GA are Locating Addiction Recovery Thanks to New Helpline 2Health News:New Helpline Provides Teen Drug & Alcohol Recovery Information in Holly Springs, NC 2Health News:Glucose Meter Industry Global (Europe, Asia, NA, ROW) Analysis Now Available at ReportsnReports.com 2Health News:Glucose Meter Industry Global (Europe, Asia, NA, ROW) Analysis Now Available at ReportsnReports.com 3Health News:AWeber: Review Exposes Affordable Provider of Opt-In Email Marketing Services 2
... for Clinical Medical Ethics at the University of Chicago awarded ... Outcomes to John E. Wennberg, MD, MPH, the Peggy Y. ... and founding editor of The Dartmouth Atlas of Health Care. ... the center,s 23rd annual conference, is the largest of its ...
... that flu strains migrate back and forth between different regions ... to the common belief that flu strains from the tropics ... research appeared online on Nov. 14 in the Proceedings ... in part by the Centers of Excellence for Influenza ...
... research from Perelman School of Medicine at the ... have an increased risk of heart attack, stroke ... moderate to severe. Now, Penn researchers have discovered ... skin disease impacts cardiovascular health. In two new ...
... using magnetic resonance imaging (MRI) to evaluate cardiovascular risk ... Mount Sinai School of Medicine have found that the ... initial dust cloud on September 11, 2001, demonstrate high-risk ... presented at the American Heart Association,s Scientific Sessions 2011 ...
... led by the University of Colorado Boulder shows that today,s ... the past and that the influence makes it more difficult ... rates were higher, people smoked for a variety of reasons," ... composition of the smoking population has changed. Smokers are ...
... identified hepcidin, a hormone that regulates iron levels in ... Suppressing hepcidin is a way to reduce the ... arterial plaques. Reducing iron levels pushes those cells to ... cholesterol transport," interfering with atherosclerosis, researchers have found. ...
Cached Medicine News:Health News:First MacLean Center Prize in Clinical Ethics awarded to Dartmouth's John Wennberg 2Health News:First MacLean Center Prize in Clinical Ethics awarded to Dartmouth's John Wennberg 3Health News:NIH grantees rebut theory that seasonal flu strains originate in tropical regions 2Health News:NIH grantees rebut theory that seasonal flu strains originate in tropical regions 3Health News:Psoriasis is associated with impaired HDL function, Penn study finds 2Health News:WTC workers exposed earlier to dust cloud have higher risk of atherosclerotic lesions 2Health News:CU-Boulder led study of smoking twins points to growing influence of genetic factors 2Health News:Hormone that controls iron levels may be target for atherosclerosis treatment 2
40-well gradient cycler...
... maximizes what a thermal cycler can do ... formats, an easy graphic interface, and best ... PCR. The iCycler thermal cycler will raise ... can do for you.,, iCycler Thermal Cycler ...
... Mastercycler personal is a high quality, compact thermal ... block homogeneity, the Mastercycler personal offers first-rate operational ... can accommodate 25 x 0.2 ml tubes, 16 ... 5 x 5 grid format. Like the Mastercycler ...
Contains: Card, cabling and instructions to remotely access a RoboCycler® instrument from a PC or Macintosh® computer...
Medicine Products: